Enquiry/Quote

How to Source Azacitidine Injection for Pharmaceutical Formulation

Azacitidine Injection (Injectable, 100 mg/vial) is classified under Oncology Cancer Care. It is therapeutically aligned with reference brands such as Vidaza®(EU & US). This guide highlights key sourcing factors buyers should consider when procuring high-quality Azacitidine Injection for formulation, R&D, or bulk manufacturing.

Product Overview: Azacitidine 50 mg and 100 mg Vials (brand name Vidaza®) are used in oncology to treat myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). As a hypomethylating agent, Azacitidine works by inhibiting DNA methylation, promoting the reactivation of genes that control blood cell growth. Available as subcutaneous or intravenous injections, it is vital for patients who are ineligible for intensive chemotherapy.

Azacitidine Injection API in Injectable form, 100 mg/vial specification
Azacitidine Injection API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.

1. Regulatory Compliance & Documentation

Ensure suppliers provide:

2. Purity, Grade & Specification Matching

Azacitidine Injection must meet exact grade and purity for your dosage form:

3. Supplier Reliability & Audit History

4. Commercial Terms: Pricing, MOQ & Flexibility

5. Lead Time, Inventory & Logistics

Typical lead time for Azacitidine Injection is 4–6 weeks.

6. Formulation Support

Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.

Conclusion

Sourcing Azacitidine Injection is more than procurement—it’s a strategic partnership. With its injectable form and 100 mg/vial specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.

Next Step: Get expert assistance in sourcing Azacitidine Injection.

Request a Quote

Frequently Asked Questions For Sourcing of Azacitidine Injection

What is the typical lead time for Azacitidine Injection?

Lead times range from 4–6 weeks depending on supplier and region.

Is Azacitidine Injection available in multiple grades?

Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.

Does Azacitidine Injection require special storage?

It should be stored in a cool, dry place away from direct sunlight.

Is a Drug Master File (DMF) available for Azacitidine Injection?

Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.

Can I request samples or a pilot batch of Azacitidine Injection?

Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.

What compliance certificates are available for Azacitidine Injection?

Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.

Is Azacitidine Injection suitable for regulated markets like US/EU?

Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.

Can Azacitidine Injection be used in fixed-dose combinations?

Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.